TY  - JOUR
T1  - Shared Decision-Making about Deprescribing in Advanced Illness: Patient, Family, and Nursing Perspectives
A1  - Aisha Rahman
A1  - Kwame Boateng
A1  - Naledi Mokoena
A1  - Li Wei
JF  - Journal of Integrative Nursing and Palliative Care
JO  - J Integr Nurs Palliat Care
SN  - 3006-5550
Y1  - 2025
VL  - 6
IS  - 2
DO  - 10.51847/lwhOYoHHPC
SP  - 416
EP  - 425
N2  - Deprescribing in advanced illness is often treated as a technical response to polypharmacy, treatment burden, or limited prognosis, yet continuation and discontinuation are also preference-sensitive decisions distributed across patients, families, nurses, prescribers, and care systems. This article develops a stakeholder shared-decision account that distinguishes medication appraisal from the relational work of eliciting goals, negotiating family involvement, clarifying professional responsibilities, and acting under uncertainty. Continued therapy, modification, staged withdrawal, deferral, and deprescribing can each be legitimate when clinically defensible and aligned with patient goals. The central contribution is a conditional view of shared deprescribing: good decisions depend on role-legible deliberation, explicit uncertainty, and sufficient capability and opportunity to implement the chosen course safely. Shared decision-making therefore neither requires unanimous agreement nor presumes that deprescribing is the preferred endpoint.
UR  - https://journalinpc.com/article/shared-decision-making-about-deprescribing-in-advanced-illness-patient-family-and-nursing-perspec-os4cucnxf6mclxr
ER  -